Psychiatric Pharmacists Led Optimization of Medication-Assisted Treatment for Substance Use Disorder
Table of Contents
Psychiatric pharmacists are playing an increasingly vital role in optimizing medication-assisted treatment (MAT) for patients with substance use disorder (SUD), notably those navigating the complexities of opioid use disorder (OUD) and polysubstance use.
The expanding scope of practise for psychiatric pharmacists, especially within systems like the Department of Veterans Affairs (VA), is driving significant improvements in patient care. These specialists are uniquely positioned to address the multifaceted challenges inherent in treating SUD, going beyond conventional prescribing to focus on complete medication management and patient education.
Expanding Access to Long-Acting Medications
A key area of impact has been increasing access to long-acting injectable medications for OUD. According to one expert, ensuring the availability of these products – frequently enough governed by Risk Evaluation and mitigation Strategies (REMS) – is paramount. “We wanted to make it easy for providers to be able to order them at the correct dosages,” thay explained. This extends beyond simply filling prescriptions; it involves educating both providers and patients on proper initiation and maintenance of these therapies.
Moreover,facilities are developing innovative protocols,such as microinduction,to make buprenorphine more accessible to individuals who might potentially be actively using opioids or unaware of concurrent substance use. This approach allows for flexible treatment options, enabling clinicians to tailor regimens to individual needs – whether starting, restarting, continuing, de-escalating, or escalating medication.
Addressing Polysubstance Use and Complex Cases
The reality of SUD frequently enough extends beyond a single substance. Many patients present with complex cases involving combinations of opioids, stimulants, and sedatives. Recognizing this, psychiatric pharmacists are pioneering strategies to address co-occurring disorders. Notably, one protocol involves utilizing phenobarbital to safely and comfortably manage benzodiazepine withdrawal. Initial results have been promising, with patients reporting considerably improved withdrawal experiences compared to traditional benzodiazepine tapering methods.
For particularly challenging cases, psychiatric pharmacists act as crucial consultants. “I’m available constantly as a consultant, so I tend to get pulled into more complex cases where ther are nuances and where the traditional approach may not work as well,” one pharmacist noted. Leveraging a strong professional network allows for rapid access to expertise and best practices. “Ashley and I have a fantastic network, so we just pick up the phone and call anyone if we have a question,” they added, highlighting the value of collaborative care.
Combating Stigma Through Education and Interaction
Beyond direct patient care, psychiatric pharmacists are actively working to reduce the stigma surrounding SUD within healthcare settings. A primary strategy involves increasing exposure and fostering interaction between patients and healthcare professionals. This begins with training future pharmacists, with experts actively engaging students during patient interactions.
“I interact with patients in the presence of learners and model how I was taught to interact with patients,” explained one pharmacist. “It’s really simple-saying good morning, smiling, and giving patients time to share what they’re experiencing with a medication.” Employing techniques like motivational interviewing and reflective listening ensures patients feel heard and validated, a crucial element often missing in other specialties.
This commitment to education extends to healthcare leadership and administration. Navigating complex regulatory landscapes – such as differing state laws regarding harm reduction tools like fentanyl test strips – requires proactive advocacy and education. “Where we shine is educating peopel and helping them understand why something is significant and why we want to make sure those tools are available to our patients,” stated a senior official. This interdisciplinary approach elevates the role of the psychiatric pharmacist as an integral member of the care team.
Ultimately, the expanding role of psychiatric pharmacists represents a significant step forward in providing comprehensive, patient-centered care for individuals struggling with substance use disorder.Their expertise in medication management, coupled with a commitment to reducing stigma and fostering collaboration, is proving invaluable in the ongoing fight against the opioid crisis and beyond.
